Dr Hong Liu - Researcher Profile

Biography

Hong works in the Faculty of Medicine, Nursing & Health Sciences at Monash University as a Research Fellow.

Qualifications

PHD

Institution: Sichuan University

Year awarded: 1997

Publications

Journal Articles

Costa, M., Sourris, K., Lim, S.M., Yu, Q.C., Hirst, C.E., Parkington, H.C., Jameson, V.J., Dear, A.E., Liu, H.B., Micallef, S.J., Koutsis, K., Elefanty, A.G., Stanley, E., 2013, Derivation of endothelial cells from human embryonic stem cells in fully defined medium enables identification of lysophosphatidic acid and platelet activating factor as regulators of eNOS localization, Stem Cell Research [P], vol 10, issue 1, Elsevier BV, The Netherlands, pp. 103-117.

Gaspari, T., Liu, H., Welungoda, I., Hu, Y., Widdop, R., Knudsen, L., Simpson, R., Dear, A., 2011, A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model, Diabetes and Vascular Disease Research [P], vol 8, issue 2, Sage Publications Ltd, UK, pp. 117-124.

Hu, Y., Liu, H., Simpson, R., Dear, A., 2011, PPAR(gamma)-independent thiazolidinedione-mediated inhibition of NUR77 expression in vascular endothelial cells, Journal of Endocrinology [P], vol 208, issue 1, BioScientifica Ltd, UK, pp. R1-R7.

Liu, H.B., Mayes, P.A., Perlmutter, P., McKendrick, J., Dear, A.E., 2011, The anti-leukemic effect and molecular mechanisms of novel hydroxamate and benzamide histone deacetylase inhibitors with 5-aza-cytidine, International Journal of Oncology [P], vol 38, issue 5, Spandidos Publications, Greece, pp. 1421-1425.

Liu, H.B., Dear, A.E., Knudsen, L.B., Simpson, R., 2009, A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules, Journal of Endocrinology [P], vol 201, issue 1, Society for Endocrinology, UK, pp. 59-66.

Restall, C., Doherty, J., Liu, H.B., Genovese, R., Paiman, L., Byron, K., Anderson, R., Dear, A.E., 2009, A novel histone deacetylase inhibitor augments tamoxifen-mediated attenuation of breast carcinoma growth, International Journal Of Cancer [P], vol 125, issue 2, John Wiley & Sons, Inc., USA, Switzerland, Germany, pp. 483-487.

Liu, H.B., VOSO, M.T., Gumiero, D., Duong, J., mckendrick, J., Dear, A.E., 2009, The anti-leukemic effect of a novel histone deacetylase inhibitor MCT-1 and 5-aza-cytidine involves augmentation of Nur77 and inhibition of MMP-9 expression, International Journal of Oncology [P], vol 34, issue 2, Spandidos Publications, Greece, pp. 573-579.

Shehu-Xhilaga, M., Rhodes, D., Wightman, F., Liu, H.B., Solomon, A., Saleh, S.M., Dear, A.E., Cameron, P.U., Lewin, S.R., 2009, The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells, AIDS [P], vol 23, issue 15, Lippincott Williams & Wilkins, United States, pp. 2047-2050.

Liu, H., Hu, Y., Simpson, R.W., Dear, A.E., 2008, Glucagon-like peptide-1 attenuates tumour necrosis factor-alpha-mediated induction of plasmogen activator inhibitor-1 expression, Journal of Endocrinology, vol 196, issue 1, Society for Endocrinology, UK, pp. 57-65.

Dear, A.E., Liu, H.B., Mayes, P.A., Perlmutter, P., 2006, Conformational analogues of Oxamflatin as histone deacetylase inhibitors, Organic & Biomolecular Chemistry, vol 4, issue 20, Royal Society of Chemistry, UK, pp. 3778-3784.

Liu, H.B., Simpson, R.W., Dear, A.E., 2006, GLP-1 attenuates TNF-alpha-mediated induction of PAI-1 expression in vascular endothelial cells, Diabetes, vol 55, issue Supl 1, American Diabetes Association, USA, p. A343.

Liu, H.B., Hu, Y.S., Medcalf, R.L., Simpson, R.W., Dear, A.E., 2005, Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation, Biochemical and Biophysical Research Communications, vol 334, Academic Press, USA, pp. 30-37.